PMC:7018936 / 8754-9730 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7018936","sourcedb":"PMC","sourceid":"7018936","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7018936","text":"The results of two patients were excluded from the analysis: one patient with an absolute basopenia (excluded from BAT analysis) and one patient with a deep lymphopenia (\u003c300/mm3, excluded from LST analysis). Negative and positive controls were acceptable for BAT (median 5.19%, range 4.16–5.50, and 85.92%, range 44.99–97.85, respectively) and LST [median 1.52% (1.10–1.97) and 65.39% (31.81–86.89) for CD8 LST, mean 1.29% (1.00–1.80) and 68.32% (45.89–85.73) for CD4 LST]. Status of lung transplantation did not influence the level of basophil activation in anti-RFcεI positive control (median 18.64, range 6.48–21.23 and median 18.54, range 11.96–21.90, p = 0.53, for transplanted and non-transplanted patients, respectively) and with all the mold extracts (median 1.68, range 0.69–4.28 and median 1.35, range 0.62–2.11, p = 0.31 for Pen; 1.35, range 0.66–6.71 and 1.38, range 0.77–20.37, p = 0.07 for Af; 1.29, range 0.60–4.48 and 1.27, range 0.72–7.77, p = 0.44 for Alt).","tracks":[]}